AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Oct 2010 07:00 AM
RNS
Transaction in Own Shares
07 Oct 2010 07:00 AM
RNS
Transaction in Own Shares
06 Oct 2010 07:00 AM
RNS
Transaction in Own Shares
05 Oct 2010 07:00 AM
RNS
Transaction in Own Shares
04 Oct 2010 02:00 PM
RNS
Total Voting Rights
04 Oct 2010 07:00 AM
RNS
Transaction in Own Shares
01 Oct 2010 07:00 AM
RNS
Transaction in Own Shares
30 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
29 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
28 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
27 Sep 2010 07:00 AM
RNS
Results of zibotentan Phase I
27 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
24 Sep 2010 01:30 PM
RNS
Brilique gets positive opinio
24 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
23 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
22 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
21 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
20 Sep 2010 05:30 PM
RNS
Form 8.3 - SILENCE THERAPEUTI
20 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
17 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
16 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
15 Sep 2010 07:00 AM
RNS
FDA extends timeline for NDA
15 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
14 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
13 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
10 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
09 Sep 2010 11:30 AM
RNS
Director/PDMR Shareholding
09 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
08 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
07 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
06 Sep 2010 04:30 PM
RNS
Director/PDMR Shareholding
06 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
03 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
02 Sep 2010 04:30 PM
RNS
Director/PDMR Shareholding
02 Sep 2010 07:00 AM
RNS
Seroquel XR gets EC approval
02 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
01 Sep 2010 06:00 PM
RNS
Director/PDMR Shareholding
01 Sep 2010 04:30 PM
RNS
Total Voting Rights
01 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
31 Aug 2010 04:30 PM
RNS
Director/PDMR Shareholding
31 Aug 2010 07:00 AM
RNS
CRL received from FDA for mot
31 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
27 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
26 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
25 Aug 2010 04:30 PM
RNS
Director/PDMR Shareholding
25 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
24 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
23 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
20 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
19 Aug 2010 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100